Not a real patient.

LYNPARZA for advanced ovarian cancer may be:

  • Taken in combination with bevacizumab if your advanced ovarian cancer has tested positive for HRD (homologous recombination deficiency) and has responded to your first treatment with platinum-based chemotherapy

OR

  • Taken alone if your advanced ovarian cancer has tested positive for a BRCA mutation and has responded to your first treatment with platinum-based chemotherapy

Your healthcare provider will perform a test to make sure that LYNPARZA is right for you.

Not a real patient.

LYNPARZA for recurrent ovarian cancer may be appropriate if your cancer:

  • Has come back (also known as recurrent ovarian cancer)
  • Has responded to the most recent treatment with platinum-based chemotherapy
  • Has tested positive for a BRCA mutation

Your healthcare provider will perform a test to make sure that LYNPARZA is right for you.